| Income Statement |
| Total Revenue | 42.00M |
|
| Revenues (USD) | 42.00M |
| Cost of Revenue | 8.66M |
| Gross Profit | 33.34M |
| Operating Expenses | 27.47M |
| Research and Development Expense | 10.84M |
| Selling, General and Administrative Expense | 12.17M |
| Operating Income | 5.87M |
| Interest Expense | 7.78M |
| Income Tax Expense | -1.80M |
| Net Income | 5.81M |
| Net Income Common Stock | 5.81M |
| Net Income Common Stock (USD) | 5.81M |
| Consolidated Income | 5.81M |
| Earnings per Basic Share | 0.55 |
| Earnings per Basic Share (USD) | 0.55 |
| Earnings per Diluted Share | 0.51 |
| Earning Before Interest & Taxes (EBIT) | 11.79M |
| Earning Before Interest & Taxes (USD) | 11.79M |
| Weighted Average Shares | 10.63M |
| Weighted Average Shares Diluted | 11.47M |
| Balance Sheet |
| Cash and Equivalents | 34.83M |
| Cash and Equivalents (USD) | 34.83M |
| Trade and Non-Trade Receivables | 17.51M |
| Current Assets | 61.02M |
| Property, Plant & Equipment Net | 7.41M |
| Total Assets | 278.22M |
| Total Debt | 173.34M |
| Current Liabilities | 39.82M |
| Debt Non-Current | 173.34M |
| Total Liabilities | 222.87M |
| Accumulated Retained Earnings (Deficit) | -442.60M |
| Accumulated Other Comprehensive Income | -13.17M |
| Shareholders Equity | 55.35M |
| Shareholders Equity (USD) | 55.35M |
| Assets Non-Current | 217.20M |
| Total Debt (USD) | 173.34M |
| Deferred Revenue | 100.00K |
| Goodwill and Intangible Assets | 207.65M |
| Liabilities Non-Current | 183.04M |
| Trade and Non-Trade Payables | 5.38M |
| Tax Liabilities | 3.32M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 4.46M |
| Net Cash Flow from Financing | -25.40M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 10.21M |
| Capital Expenditure | -3.50M |
| Issuance (Repayment) of Debt Securities | -25.40M |
| Net Cash Flow from Investing | -3.50M |
| Net Cash Flow from Operations | 39.36M |
| Effect of Exchange Rate Changes on Cash | -254.00K |
| Share Based Compensation | 1.14M |